No abstract
Lancet Diabetes Endocrinol. 2026 Feb;14(2):105-108. doi: 10.1016/S2213-8587(25)00356-0.
NO ABSTRACT
PMID:41519598 | DOI:10.1016/S2213-8587(25)00356-0
GLP-1 receptor agonists for obesity: eligibility across 99 countries
Scritto il 10/01/2026
da Sang Gune K Yoo